These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 30188764)
1. Evaluation of the diagnostic value of emerin and CD56 in papillary thyroid carcinoma - an immunohistochemical study. Abdou AG; Abdelwahed M; Said A; Taie DM; Fahmy S J Immunoassay Immunochem; 2018; 39(5):521-537. PubMed ID: 30188764 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics. Abouhashem NS; Talaat SM Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214 [TBL] [Abstract][Full Text] [Related]
3. Expression of HBME-1 and CD56 in follicular variant of papillary carcinoma in children: An immunohistochemical study and their diagnostic utility. Skaria PE; Ahmed AA; Yin H; Nicol K; Reid KJ; Singh V Pathol Res Pract; 2019 May; 215(5):880-884. PubMed ID: 30711197 [TBL] [Abstract][Full Text] [Related]
4. Papillary thyroid tumors: Diagnostic value of CD56 and Cytokeratin 19. Zehani A; Bani A; Chelly I; Rejaibi S; Besbes G; Haouet S; Kchir N Tunis Med; 2018 Feb; 96(2):113-121. PubMed ID: 30324976 [TBL] [Abstract][Full Text] [Related]
5. The absence of CD56 expression can differentiate papillary thyroid carcinoma from other thyroid lesions. Golu I; Vlad MM; Dema A; Moleriu LC; Tudor A; Iacob M; Popa O; Cornianu M Indian J Pathol Microbiol; 2017; 60(2):161-166. PubMed ID: 28631628 [TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma. Yang X; Hu Y; Shi H; Zhang C; Wang Z; Liu X; Chen H; Zhang L; Cui D Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2127-2134. PubMed ID: 29951933 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of CD56 immunohistochemistry in thyroid lesions. Pyo JS; Kim DH; Yang J Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356 [TBL] [Abstract][Full Text] [Related]
8. CD56 expression in benign and malignant thyroid lesions. Muthusamy S; Azhar Sha S; Abdullah Suhaimi SN; Kassim N; Mahasin M; Mohd Saleh MF; Md Isa N Malays J Pathol; 2018 Aug; 40(2):111-119. PubMed ID: 30173227 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of CD56 and nm23 markers in papillary thyroid carcinoma. Shahebrahimi K; Madani SH; Fazaeli AR; Khazaei S; Kanani M; Keshavarz A Indian J Pathol Microbiol; 2013; 56(1):2-5. PubMed ID: 23924549 [TBL] [Abstract][Full Text] [Related]
10. The value of tumor markers in the diagnosis of papillary thyroid carcinoma alone and in combination. Ma H; Xu S; Yan J; Zhang C; Qin S; Wang X; Li N Pol J Pathol; 2014 Oct; 65(3):202-9. PubMed ID: 25372417 [TBL] [Abstract][Full Text] [Related]
11. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin. Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548 [TBL] [Abstract][Full Text] [Related]
13. Emerin expression in well differentiated epithelial lesions of thyroid: implications in papillary thyroid carcinoma diagnosis and predicting malignant behavior. Coban I; Cakir A; Unal TD; Bassullu N; Karpuz V; Dogusoy GB; Alper M Pathol Oncol Res; 2015 Apr; 21(2):357-66. PubMed ID: 25116851 [TBL] [Abstract][Full Text] [Related]
14. Cytological detection of papillary thyroid carcinomas by nuclear membrane decoration with emerin staining. Asioli S; Maletta F; Pacchioni D; Lupo R; Bussolati G Virchows Arch; 2010 Jul; 457(1):43-51. PubMed ID: 20502915 [TBL] [Abstract][Full Text] [Related]
15. Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma. Mai KT; Landry DC; Thomas J; Burns BF; Commons AS; Yazdi HM; Odell PF Histopathology; 2001 Jul; 39(1):25-32. PubMed ID: 11454041 [TBL] [Abstract][Full Text] [Related]
16. TROP-2 immunohistochemistry: a highly accurate method in the differential diagnosis of papillary thyroid carcinoma. Bychkov A; Sampatanukul P; Shuangshoti S; Keelawat S Pathology; 2016 Aug; 48(5):425-33. PubMed ID: 27311870 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid. El Demellawy D; Nasr AL; Babay S; Alowami S Pathol Res Pract; 2009; 205(5):303-9. PubMed ID: 19153015 [TBL] [Abstract][Full Text] [Related]
18. [Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis]. He CN; He L; Cheng JQ; Chen SC; Zhao HF; Zhai JP; Zhang J Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):35-9. PubMed ID: 18509983 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules. Mai KT; Ford JC; Yazdi HM; Perkins DG; Commons AS Pathol Res Pract; 2000; 196(8):533-40. PubMed ID: 10982016 [TBL] [Abstract][Full Text] [Related]
20. Thyroid tumors of uncertain malignant potential: morphologic and imunohistochemical analysis of 29 cases. Nechifor-Boila A; Borda A; Sassolas G; Hafdi-Nejjari Z; Cătană R; Borson-Chazot F; Berger N; Decaussin-Petrucci M Pathol Res Pract; 2015 Apr; 211(4):320-5. PubMed ID: 25595997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]